SCHEMBL13680565

SCHEMBL13680565

Cc1cccc(-c2ccc3oc(=O)[nH]c3c2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 2/20 0.54
PDE3A Q14432 2/20 0.54
NOS1 P29475 5/20 0.53
NOS2 P35228 4/20 0.53
NOS3 P29474 3/20 0.53
AKT1 P31749 1/20 0.46
AKT2 P31751 1/20 0.46
AKT3 Q9Y243 1/20 0.46
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
ADRA2A P08913 1/20 0.45
TSHR P16473 1/20 0.45
THPO P40225 1/20 0.45
BLM P54132 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
OGT O15294 1/20 0.42
SYK P43405 1/20 0.42
CFTR P13569 1/20 0.42
CDC25A P30304 1/20 0.41
CDC25B P30305 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11256932 0.80 PDE3B (0.63) PDE3BPDE3ANOS1NOS2NOS3
SCHEMBL13680558 0.78 GRIA1 (0.59) PDE3BPDE3ACDC25ACDC25BCDC25C
SCHEMBL11251865 0.77 PDE3B (0.60) PDE3BPDE3ANOS1NOS2NOS3
SCHEMBL4256962 0.77 NOS1 (0.68) PDE3BPDE3ANOS1NOS2NOS3
SCHEMBL11258651 0.74 PDE3B (0.68) PDE3BPDE3ANOS1NOS2NOS3
SCHEMBL13680622 0.74 PDE3B (0.56) PDE3BPDE3ANOS1NOS2NOS3
SCHEMBL24348919 0.73 BPGM (0.66) PDE3BPDE3ANOS1NOS2NOS3
SCHEMBL17260645 0.72 PDE3B (0.71) PDE3BPDE3ANOS1NOS2NOS3
SCHEMBL13680450 0.71 CA12 (0.53) PDE3BPDE3ACYP2A6CCR1CCR8
SCHEMBL15592396 0.71 PPM1D (0.66) PDE3BPDE3ANOS1OGTSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed